{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T03:25:30Z","timestamp":1791516330546,"version":"4.3.4"},"reference-count":38,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,2,27]],"date-time":"2020-02-27T00:00:00Z","timestamp":1582761600000},"content-version":"am","delay-in-days":363,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"Takeda and Pfizer"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","dldjournalonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Digestive and Liver Disease"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.dld.2018.12.010","type":"journal-article","created":{"date-parts":[[2018,12,23]],"date-time":"2018-12-23T11:55:49Z","timestamp":1545566149000},"page":"358-363","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"title":["Deep remission on magnetic resonance imaging impacts outcomes of perianal fistulizing Crohn\u2019s disease"],"prefix":"10.1016","volume":"51","author":[{"given":"Marion","family":"Chambaz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikael","family":"Verdalle-Cazes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Desprez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucie","family":"Thomassin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clo\u00e9","family":"Charpentier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9bastien","family":"Grigioni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Armengol-Debeir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val\u00e9rie","family":"Bridoux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Savoye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9line","family":"Savoye-Collet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.dld.2018.12.010_bib0005","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1053\/gast.2002.32362","article-title":"The natural history of fistulizing Crohn\u2019s disease in Olmsted County, Minnesota","volume":"122","author":"Schwartz","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2018.12.010_bib0010","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1053\/j.gastro.2011.01.055","article-title":"Epidemiology and natural history of inflammatory bowel diseases","volume":"140","author":"Cosnes","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2018.12.010_bib0015","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1097\/MIB.0000000000000315","article-title":"Guidelines for the multidisciplinary management of Crohn\u2019s perianal fistulas: summary statement","volume":"21","author":"Schwartz","year":"2015","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.dld.2018.12.010_bib0020","first-page":"533","article-title":"Metronidazole therapy for Crohn\u2019s disease and associated fistulae","volume":"79","author":"Jakobovits","year":"1984","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2018.12.010_bib0025","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1046\/j.1365-2036.2003.01793.x","article-title":"Antibiotics and azathioprine for the treatment of perianal fistulas in Crohn\u2019s disease","volume":"18","author":"Dejaco","year":"2003","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.dld.2018.12.010_bib0030","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1056\/NEJM199905063401804","article-title":"Infliximab for the treatment of fistulas in patients with Crohn\u2019s disease","volume":"340","author":"Present","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.dld.2018.12.010_bib0035","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1056\/NEJMoa030815","article-title":"Infliximab maintenance therapy for fistulizing Crohn\u2019s disease","volume":"350","author":"Sands","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.dld.2018.12.010_bib0040","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1053\/j.gastro.2006.11.041","article-title":"Adalimumab for maintenance of clinical response and remission in patients with Crohn\u2019s disease: the CHARM trial","volume":"132","author":"Colombel","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2018.12.010_bib0045","doi-asserted-by":"crossref","first-page":"829","DOI":"10.7326\/0003-4819-146-12-200706190-00159","article-title":"Adalimumab induction therapy for Crohn disease previously treated with infliximab: a randomized trial","volume":"146","author":"Sandborn","year":"2007","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.dld.2018.12.010_bib0050","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1056\/NEJMoa0904492","article-title":"Infliximab, azathioprine, or combination therapy for Crohn\u2019s disease","volume":"362","author":"Colombel","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.dld.2018.12.010_bib0055","first-page":"299","article-title":"Treatment of complex perianal fistulas in Crohn disease: infliximab, surgery or combined approach","volume":"53","author":"Sciaudone","year":"2010","journal-title":"Can J Surg J Can Chir"},{"key":"10.1016\/j.dld.2018.12.010_bib0060","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1093\/ecco-jcc\/jjw039","article-title":"Results of the fifth scientific workshop of the ECCO [II]: clinical aspects of perianal fistulising Crohn\u2019s disease-the unmet needs","volume":"10","author":"Gecse","year":"2016","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.dld.2018.12.010_bib0065","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1038\/ajg.2011.73","article-title":"Efficacy of biological therapies in inflammatory bowel disease: systematic review and meta-analysis","volume":"106","author":"Ford","year":"2011","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2018.12.010_bib0070","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/j.cgh.2012.12.042","article-title":"Long-term outcome of perianal fistulizing Crohn\u2019s disease treated with infliximab","volume":"11","author":"Bouguen","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2018.12.010_bib0075","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1007\/s10620-008-0545-y","article-title":"Predicting factors of fistula healing and clinical remission after infliximab-based combined therapy for perianal fistulizing Crohn\u2019s disease","volume":"54","author":"Tougeron","year":"2009","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.dld.2018.12.010_bib0080","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/S0002-9270(02)05909-9","article-title":"Magnetic resonance imaging of the effects of infliximab on perianal fistulizing Crohn\u2019s disease","volume":"98","author":"Van Assche","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2018.12.010_bib0085","doi-asserted-by":"crossref","first-page":"2973","DOI":"10.1038\/ajg.2009.509","article-title":"Prospective evaluation of anti-tumor necrosis factor therapy guided by magnetic resonance imaging for Crohn\u2019s perineal fistulas","volume":"104","author":"Ng","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2018.12.010_bib0090","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1046\/j.1365-2036.2003.01427.x","article-title":"Response of fistulazing Crohn\u2019s disease to infliximab treatment assessed by magnetic resonance imaging","volume":"17","author":"Bell","year":"2003","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.dld.2018.12.010_bib0095","first-page":"130","article-title":"Long-term monitoring of infliximab therapy for perianal fistulizing Crohn\u2019s disease by using magnetic resonance imaging","volume":"9","author":"Karmiris","year":"2011","journal-title":"Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc"},{"key":"10.1016\/j.dld.2018.12.010_bib0100","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1002\/ibd.21940","article-title":"Long-term MRI-guided combined anti- TNF-\u03b1 and thiopurine therapy for Crohn\u2019s perianal fistulas","volume":"18","author":"Tozer","year":"2012","journal-title":"Inflamm. Bowel Dis"},{"key":"10.1016\/j.dld.2018.12.010_bib0105","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1053\/j.gastro.2009.09.056","article-title":"Mucosal healing predicts sustained clinical remission in patients with early-stage Crohn\u2019s disease","volume":"138","author":"Baert","year":"2010","journal-title":"Gastroenterology"},{"issue":"Suppl 3","key":"10.1016\/j.dld.2018.12.010_bib0110","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1159\/000342732","article-title":"Deep remission: a new concept?","volume":"30","author":"Colombel","year":"2012","journal-title":"Dig Dis Basel Switz"},{"key":"10.1016\/j.dld.2018.12.010_bib0115","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1136\/gut.2005.082909","article-title":"The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications","volume":"55","author":"Satsangi","year":"2006","journal-title":"Gut"},{"key":"10.1016\/j.dld.2018.12.010_bib0120","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1002\/ibd.21568","article-title":"Fistulizing perianal Crohn's disease : contrast-enhanced magnetic resonance imaging assessment at 1 year on maintenance anti-TNFalpha therapy","volume":"17","author":"Savoye-Collet","year":"2011","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.dld.2018.12.010_bib0125","doi-asserted-by":"crossref","first-page":"4285","DOI":"10.3748\/wjg.v23.i23.4285","article-title":"MRI may predict deep remission in patients with perianal fistulizing Crohn's disease","volume":"23","author":"Thomassin","year":"2017","journal-title":"WJG"},{"key":"10.1016\/j.dld.2018.12.010_bib0130","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1038\/ajg.2014.424","article-title":"Characterization of inflammation and fibrosis in Crohn\u2019s disease lesions by magnetic resonance imaging","volume":"110","author":"Rimola","year":"2015","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2018.12.010_bib0135","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1038\/ajg.2010.35","article-title":"How deep is remission in perianal Crohn\u2019s disease and do imaging modalities matter?","volume":"105","author":"Savoye","year":"2010","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2018.12.010_bib0140","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1148\/radiol.2512072128","article-title":"Perianal Crohn disease: evaluation of dynamic contrast enhanced MR imaging as an indicator of disease activity","volume":"251","author":"Horsthuis","year":"2009","journal-title":"Radiology"},{"key":"10.1016\/j.dld.2018.12.010_bib0145","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1002\/jmri.25325","article-title":"Diffusion-weighted MRI in Crohn\u2019s disease: current status and recommendations","volume":"44","author":"Dohan","year":"2016","journal-title":"J Magn Reson Imaging"},{"key":"10.1016\/j.dld.2018.12.010_bib0150","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1007\/s00330-016-4350-2","article-title":"Magnetization transfer ratio for the assessment of perianal fistula activity in Crohn\u2019s disease","volume":"27","author":"Pinson","year":"2017","journal-title":"Eur Radiol"},{"key":"10.1016\/j.dld.2018.12.010_bib0155","first-page":"915","article-title":"Current evidence supporting mucosal healing and deep remission as important treatment goals for inflammatory bowel disease","volume":"10","author":"Pineton de Chambrun","year":"2016","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2018.12.010_bib0160","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.cgh.2013.06.019","article-title":"Adalimumab induces deep remission in patients with Crohn's disease","volume":"12","author":"Colombel","year":"2014","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2018.12.010_bib0165","first-page":"A-618","article-title":"Endoscopic healing after infliximab treatment for Crohn's disease provides a longer time to relapse","volume":"122","author":"D\u2019Haens","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2018.12.010_bib0170","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1053\/j.gastro.2011.09.034","article-title":"Maintenance of remission among patients with Crohn's disease on antimetabolite therapy after infliximab therapy is stopped","volume":"142","author":"Louis","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2018.12.010_bib0175","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1093\/ibd\/izy008","article-title":"Outcomes of Perianal Fistulising Crohn\u2019s Disease Following Anti-TNF\u03b1 treatment discontinuation","volume":"24","author":"Legu\u00e9","year":"2018","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.dld.2018.12.010_bib0180","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1111\/apt.13970","article-title":"Higher infliximab trough levels are associated with perianal fistula healing in patients with Crohn\u2019s disease","volume":"45","author":"Yarur","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.dld.2018.12.010_bib0185","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1016\/j.crohns.2014.02.028","article-title":"Prospective validation study of the International Classification of Functioning, Disability and Health score in Crohn's disease and ulcerative colitis","volume":"8","author":"Leong","year":"2014","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.dld.2018.12.010_bib0190","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1136\/gutjnl-2015-310151","article-title":"Validation of the Inflammatory Bowel Disease Disability Index in a population-based cohort","volume":"66","author":"Gower-Rousseau","year":"2017","journal-title":"Gut"}],"container-title":["Digestive and Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865818313057?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865818313057?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T04:09:23Z","timestamp":1761624563000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1590865818313057"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":38,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["S1590865818313057"],"URL":"https:\/\/doi.org\/10.1016\/j.dld.2018.12.010","relation":{},"ISSN":["1590-8658"],"issn-type":[{"value":"1590-8658","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Deep remission on magnetic resonance imaging impacts outcomes of perianal fistulizing Crohn\u2019s disease","name":"articletitle","label":"Article Title"},{"value":"Digestive and Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dld.2018.12.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier Ltd on behalf of Editrice Gastroenterologica Italiana S.r.l.","name":"copyright","label":"Copyright"}]}}